Schedule 13G ownership disclosure
BOLT BIOTHERAPEUTICS INC
Common Stock, par value $0.00001 per share · CUSIP: 097702203
Event date: 2026-10-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Coastlands Capital LP
Shares: 412,416.00 · Class: 17.50%
- Coastlands Capital Partners LP
Shares: 412,416.00 · Class: 17.50%
- Coastlands Capital GP LLC
Shares: 412,416.00 · Class: 17.50%
- Coastlands Capital LLC
Shares: 412,416.00 · Class: 17.50%
- Matthew D. Perry
Shares: 412,416.00 · Class: 17.50%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-123999
- Form type
- SCHEDULE 13G
- Filer
- Coastlands Capital LP
- CIK
- CIK 2068530
- Filed
- Nov 06, 2026
- Reporting period
- Oct 30, 2026
- Description
- Schedule 13G beneficial ownership